Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Deferred Taxes: 2009-2024

Historic Deferred Taxes for Lifecore Biomedical (LFCR) over the last 16 years, with May 2024 value amounting to $163,000.

  • Lifecore Biomedical's Deferred Taxes rose 372.50% to $109,000 in Q4 2024 from the same period last year, while for Nov 2024 it was $136,000, marking a year-over-year decrease of 66.50%. This contributed to the annual value of $163,000 for FY2024, which is 54.34% down from last year.
  • As of FY2024, Lifecore Biomedical's Deferred Taxes stood at $163,000, which was down 54.34% from $357,000 recorded in FY2023.
  • Lifecore Biomedical's Deferred Taxes' 5-year high stood at $357,000 during FY2023, with a 5-year trough of -$7.9 million in FY2021.
  • Its 3-year average for Deferred Taxes is -$2.1 million, with a median of $163,000 in 2024.
  • In the last 5 years, Lifecore Biomedical's Deferred Taxes tumbled by 697.80% in 2020 and then surged by 105.23% in 2023.
  • Over the past 5 years, Lifecore Biomedical's Deferred Taxes (Yearly) stood at -$5.4 million in 2020, then crashed by 44.74% to -$7.9 million in 2021, then grew by 13.32% to -$6.8 million in 2022, then surged by 105.23% to $357,000 in 2023, then plummeted by 54.34% to $163,000 in 2024.